A man discovered he was positive for HIV 6 years ago when he sought help because of a lung infection that turned out to be PCP. He gets his viral load and blood checked every 6 months; the lowest CD4+ T cell count he ever had was 4 years ago when his count was 318. At that time, he started taking ARVs. His CD4+ T cell/total lymphocyte ratio has never been lower than 20%. He has been undetectable for HIV for the last 3 years and his CD4+ T cells are generally around 600 and above 45%. Which of the following statements is FALSE? Select one: a. He started ART too late. b. He has never had an AIDS diagnosis. c. He is currently unlikely to transmit his HIV to a partner. d. He has HIV disease. e. He can expect to have a relatively normal life span.
Added by Myra M.
Step 1
He started ART too late. - This statement could be considered FALSE. The decision to start antiretroviral therapy (ART) is based on a number of factors, including CD4+ T cell count, the presence of symptoms, and the individual's readiness to start therapy. In this Show more…
Show all steps
Your feedback will help us improve your experience
Labs
Want to see this concept in action?
Explore this concept interactively to see how it behaves as you change inputs.
Key Concepts
Recommended Videos
A study is conducted in patients with HIV. The primary outcome is CD4 cell count which is a measure of the stage of the disease. Lower CD4 counts are associated with more advanced disease. The investigators are interested in the association between vitamin and mineral supplements and CD4 count. A multiple regression analysis is performed relating CD4 count to use of supplements (coded as 1=yes, 0=no) and to duration of HIV, in years (i.e., the number of years between the diagnosis of HIV and the study date). For the analysis, Y=CD4 count. Ŷ = 501.41 + 12.67 Supplements – 30.23 Duration of HIV A. What is the expected CD4 count for a patient taking supplements who has had HIV for 2.5 years? Ŷ = ________ B. What is the expected CD4 count for a patient not taking supplements who was diagnosed with HIV at study enrollment? Ŷ = ________ C. What is the expected CD4 count for a patient not taking supplements who has had HIV for 2.5 years. Ŷ = ________
Adi S.
In the late 1990s, a group of individuals was discovered who remained uninfected with HIV, despite multiple exposures to the virus. Analysis indicated that these HIV-resistant individuals had a homozygous deficiency caused by a 32-bp deletion in a single gene. Furthermore, this mutation was present at a frequency of approximately 10% (in heterozygous form) in individuals of European descent. These data provided clear evidence indicating that: A. Healthy individuals can have a genetic deficiency in the expression of CD4. B. Testing for HIV by seroconversion does not identify all infected individuals. C. HIV infection requires a co-receptor in addition to CD4. D. Some individuals can be infected with HIV but not develop AIDS. E. Both R5 and X4 variants of HIV are equally important in HIV transmission.
Madhur L.
HIV in sub-Saharan Africa. In July 2008, the US National Institutes of Health announced that it was stopping a clinical study early because of unexpected results. The study population consisted of HIV-infected women in sub-Saharan Africa who had been given a single dose of Nevirapine (a treatment for HIV) while giving birth to prevent transmission of HIV to the infant. The study was a randomized comparison of continued treatment of a woman (after successful childbirth) with Nevirapine vs. Lopinavir, a second drug used to treat HIV. 240 women participated in the study; 120 were randomized to each of the two treatments. Twenty-four weeks after starting the study treatment, each woman was tested to determine if the HIV infection was becoming worse (an outcome called virologic failure). Twenty-six of the 120 women treated with Nevirapine experienced virologic failure, while 10 of the 120 women treated with the other drug experienced virologic failure. (a) Create a two-way table presenting the results of this study. (b) State appropriate hypotheses to test for independence of treatment and virologic failure. (c) Complete the hypothesis test and state an appropriate conclusion. (Reminder: Verify any necessary conditions for the test.)
Recommended Textbooks
Biology for AP Courses
Objective Biology for NEET
Introduction to General, Organic and Biochemistry
Transcript
Watch the video solution with this free unlock.
EMAIL
PASSWORD